MarketPulse
S

$SION

4 articles found
3 positive
0 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Sionna Therapeutics to Showcase Cystic Fibrosis Pipeline at Major June 2026 Conferences

Sionna Therapeutics will present at Jefferies and Goldman Sachs healthcare conferences in June 2026, showcasing its cystic fibrosis pipeline.
SIONinvestor conferencecystic fibrosis
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Sionna Therapeutics to Present CF Pipeline at RBC Capital Markets Healthcare Conference

Sionna Therapeutics will present its cystic fibrosis pipeline at RBC Capital Markets Healthcare Conference on May 20, 2026, showcasing NBD1 stabilizer candidates targeting F508del mutation.
SIONcystic fibrosisclinical-stage biopharmaceutical
The Motley FoolThe Motley Fool··Jonathan Ponciano

Sionna Director Sells $2.5M Stock Amid 215% Surge; Cash Position Remains Robust

Sionna director sells $2.5M in stock (2% of holdings) during 215% surge; $310M cash position supports pipeline through 2028.
SIONbiotechportfolio rebalancing
The Motley FoolThe Motley Fool··Seena Hassouna

Sionna CLO Liquidates Full Stock Position While Holding Significant Options

Sionna CLO liquidated 10,250 shares for $347k via pre-scheduled plan while retaining 50,935 options. Dual clinical trials expected mid-2026 with $310.3M cash runway through 2028.
SIONbiotechclinical trials
$SION Stock News & Sentiment | MarketPulse